MEVINOLINDERIVATE

European patent · EP1154988 · Deleted

Register entry

Publication number
EP1154988
Application number
EP00916832
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 14, 2000
Published
Nov 21, 2001
Granted
Aug 11, 2004
Deleted
Feb 28, 2011
Reason
Annual fee unpaid
IPC classes
C07C 235/26 (2006.01)
C07C 237/18 (2006.01)
C07C 235/30 (2006.01)
C07C 237/20 (2006.01)
C07D 211/76 (2006.01)
C07D 265/24 (2006.01)
C07D 401/06 (2006.01)
A61K 31/4402 (2006.01)
A61K 31/45 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/535 (2006.01)
A61P 9/10 (2006.01)
A61P 3/06 (2006.01)
A61P 29/00 (2006.01)
A61P 37/00 (2006.01)
Priority
GB 9903546 16.02.1999
GB 9927880 25.11.1999
PCT application
PCT/EP2000/001191 14.02.2000
PCT publication
WO2000/048989 24.08.2000
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 21, 2011

    Deleted, fee unpaid

    Published in Swissreg on 21.09.2011

  2. Aug 13, 2004

    Granted

    Published in +pat+ No 15 in 2004

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

BAENTELI, Rolf

CH-4054 Basel

BAUER, Wilfried

CH-4432 Lampenberg

COTTENS, Sylvain

CH-4108 Witterswil

EHRHARDT, Claus

D-79541 Lörrach, DE

HOMMEL, Ulrich

79379 Müllheim, DE

KALLEN, Jörg

CH-4054 Basel

MEINGASSNER, Josef, Gottfried

A-2380 Perchtoldsdorf, AT

NUNINGER, François

F-68270 Wittenheim, FR

WEITZ-SCHMIDT, Gabriele

D-79189 Bad-Krozingen, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.